Microfluidics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28
                     Global Microfluidics 
Market Research and 
Forecast Report 2023-
2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  the  la tes t  r epo r t  by  IMARC Group ,  t i t l ed  "Micro f lu id ics  Market :  
G loba l  I ndust ry  T rends ,  Share ,  S ize ,  Grow th ,  Opportun i ty  and  Forecast  2023-
2028, "  t he  g loba l  m ic ro f lu id i cs  marke t  s i ze  reached  US$ 24 .7  B i l l i on  in  2022 .
M ic ro f lu id i cs  re fe rs  to  a  techno log ica l  me thod  tha t  i s  adop ted  in  o rder  t o  s tudy  
Report t he  na tu re  and  cha rac te r i s t i cs  o f  f l u ids .  I t s  u t i l i za t ion  invo lves  a  se t  o f  t oo ls  t ha t  a re  genera l l y  used f o r  man ipu la t ing  and  cont ro l l i ng  the  chemica l  and  b io log i ca l  
p rocesses  o f  smal l  vo lumes  o f  f l u ids .  
Highlight and Along  w i th  t h i s ,  i t  i s  app l i ed  in  t he  m anuf ac tu r ing  o f  m ic romin ia tu r i zed  dev ices  
tha t  con ta in  numerous  t unne ls  and  chambers  th rough  wh ich  f lu ids  f l ow o r  a re  
Description con f ined .  I n  compar ison  to  conven t iona l  f l u i d  measur ing  dev i ces ,  i t  needs  lesse r  samp les ,  t he  too ls  a re  compac t  in  s i ze  and  i t  o f f e rs  exce l len t  pa ramet e r  con t ro l  
and  da ta  qua l i t y .  As  a  resu l t ,  i t  i s  w ide ly  used  fo r  DNA ana l ys is ,  separa t i on  and 
man ipu la t ion  o f  ce l l s  and  PCR ampl i f i ca t ion .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/m ic ro f lu id i cs -marke t / reques t sample
Report Description
Gl o b a l  M i c r o f l u id i c s  M a r k e t  T r e n d s :
T he  g l o b a l  ma r ke t  i s  p r i ma r i l y  d r i v en  b y  t h e  i n c r e a s i n g  p r o du c t  d em a n d  f r o m  me d i c a l  r es e a r ch .  C o u p l ed  w i th  t h e  r i s i n g  
p r e v a l en c e  o f  i n fe c t i o ns  o n  t h e  g l o b a l  l e v e l ,  t h i s  i s  c r e a t i ng  a  po s i t i v e  ma r k e t  o u t l o o k .  Mo r e o ve r ,  t h e  w i d es p r e ad  d e m a nd  f o r  
ra p i d  t es t i n g  k i t s  o n  a c c o un t  o f  t h e  s ud d e n  o u t b r e ak  o f  c o r o n av i r u s  d i s e a s e  ( C O V I D - 1 9 )  i s  c a ta l y z i n g  t h e  d em a n d  f o r  
m i c r o f l u i d i c s .  I n  a d d i t i o n  t o  t h i s ,  t h e  g ro w i n g  i nv es t m en t s  b y  l e a d i n g  p l a y e r s  i n  t h e  d ev e l o p me n t  o f  a dv a n ce d  p o i n t - t o - c a r e  
(P O C )  d e v i c es  a r e  i m p a c t i n g  t h e  m a r k e t  g ro w t h  f a v o r ab l y .
A l o n g  w i t h  t h i s ,  e x te n s i v e  r e s e a r c h  a nd  d e v e l o p m en t  ( R & D )  a c t i v i t i e s  co n d u c t e d  b y  k e y  p l a y e r s  i n  t h e  f i e l d  o f  l i f e  sc i e n c e  a r e  
p r o v i d i n g  a n  i m p e t us  t o  t h e  ma r k e t .  A d d i t i o n a l l y ,  c o n t i nu a l  t e c h no l o g i c a l  ad v a n c e me n t s  i n  m i c r o f l u i d i c s  a n d  t he  i n t r o d uc t i o n  
o f  m i n i a tu r i z e d  p ro d u c t  v a r i a n ts  a r e  c on s i d e re d  t o  b e  ma j o r  g r o w t h - i nd u c i n g  f a c t o r s .  O t h e r  f a c t o r s ,  i n c l u d i n g  c o n t i nu o u s  
i mp r o v em e n t s  i n  t he  h e a l t h ca r e  a n d  p ha r m ac e u t i c a l  i n f r a s t ru c t u r es ,  t h e  a ug m e n t i n g  n u mb e r  o f  r e s ea r c h  l a bo r a t o r i e s  a n d  
d i a g n o s t i c  c e n t e r s ,  an d  t h e  a d o p t i o n  o f  n o v e l  t h e r ap e u t i c s  a m o ng  t he  m a ss e s ,  a re  a l s o  p o s i t i ve l y  i n f l ue n c i n g  t h e  ma r k e t .
L o o k i n g  f o rw a r d ,  t h e  m ar k e t  i s  an t i c ip a t e d  t o  r e a c h  a  v a l u e  o f  U S $  6 1 . 0  B i l l i o n  b y  2 0 28 ,  e xh i b i t i n g  a  C A G R  o f  1 6 .2 %  
d u r i n g  2 0 2 3 -2 0 2 8 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w ww . i m a r c g ro u p . co m / m i c r o f lu i d i c s - m a rk e t
Breakup by Material:
• Si l icon
• Glass
• Polymer
• PDMS
• Others
Report  
Breakup by Component:
Segmentation • Microfl uidic Chips
• Micro Pumps
• Microneedles
• Others
Breakup by Application:
• Pharmaceut ical  and Life Science Research
• Clinical  and Veterinary Diagnost ics
• Point-of-Care Diagnost ics
• Analytical  Devices
• Drug Del ivery
• Others
Report 
Breakup by Region:
Segmentation • North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Abbott Laboratories
• Agi lent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Blacktrace Holdings Ltd
Competitive 
• Elvesys Group
Landscape • Fluidigm Corporat ion
with Key • I l lumina Inc.
• Micronit B.V.
Players
• Parker-Hannifi n Corporation
• PerkinElmer Inc.
• Qiagen N.V.
• Thermo Fisher Scient ifi c Inc.
How has the global microfluidics market performed 
so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the 
global microfluidics market?
Key 
Questions What are the key regional markets?
Answered in 
What is the breakup of the market based on the 
the Report material?
What is the breakup of the market based on the 
component?
What is the breakup of the market based on the 
application?
What are the various stages in the value chain of 
the industry?
What are the key driving factors and challenges in 
the industry?
Key What is the structure of the global microfluidics 
market and who are the key players?
Questions 
Answered in What is the degree of competition in the industry?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  M i c r o f l u i d i c s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  M a t e r i a l
    6 . 1     S i l i c o n
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     G l a s s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     P o l y m e r
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     P D M S
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     O t h e r s
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  C o m p o n e n t
    7 . 1     M i c r o f l u i d i c  C h i p s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     M i c r o  P u m p s
Table of         7 . 2 . 1  M a r k e t  T r e n d s        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     M i c r o n e e d l e s
        7 . 3 . 1  M a r k e t  T r e n d s
Contents         7 . 3 . 2  M a r k e t  F o r e c a s t    7 . 4     O t h e r s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     P h a r m a c e u t i c a l  a n d  L i f e  S c i e n c e  R e s e a r c h
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     C l i n i c a l  a n d  V e t e r i n a r y  D i a g n o s t i c s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     P o i n t - o f - C a r e  D i a g n o s t i c s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /m i c ro fl u i d i c s -m arke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]